Literature DB >> 9548033

Maternal nutritional status, diabetes and risk of macrosomia among Native Canadian women.

L E Caulfield1, S B Harris, E A Whalen, M E Sugamori.   

Abstract

Multivariate methods were used to identify risk factors for macrosomia (birth weight > 4000 g) among 741 singleton births to Native Canadian women from Sioux Lookout Zone, Ontario, Canada, in 1990-1993. The average birth weight was 3691 +/- 577 g, and 29.2% of infants weighed more than 4000 g at birth. Macrosomic infants were born at later gestational ages and were more likely to be male. Women delivering macrosomic infants were taller, entered pregnancy with higher body mass indexes (BMI) and gained more weight during pregnancy, but were less likely to smoke cigarettes. They were more likely to have previously delivered a macrosomic infant and to have had gestational diabetes mellitus (GDM). Risk of macrosomia was associated with maternal glycemic status; women with pre-existing diabetes were at greatest risk, followed by those with GDM A2 (fasting glucose > or = 6 mmol/l). Women with GDM A1 (fasting glucose < 6 mmol/l) were not at increased risk for delivering a macrosomic infant, but glucose-tolerant women with high glucose concentrations 1 h after the 50 g challenge were at somewhat increased risk. Maternal glycemic status and maternal nutritional status before and during pregnancy are important determinants of macrosomia in this native population.

Entities:  

Mesh:

Year:  1998        PMID: 9548033     DOI: 10.1016/s0378-3782(97)00074-1

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  14 in total

1.  Overweight and obesity among North American Indian infants, children, and youth.

Authors:  Lawrence M Schell; Mia V Gallo
Journal:  Am J Hum Biol       Date:  2012-03-01       Impact factor: 1.937

2.  Risk reduction for type 2 diabetes in Aboriginal children in Canada.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-01       Impact factor: 2.253

3.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-01       Impact factor: 2.253

4.  Birth outcomes and infant mortality among First Nations Inuit, and non-Indigenous women by northern versus southern residence, Quebec.

Authors:  Zhong-Cheng Luo; Russell Wilkins; Maureen Heaman; Janet Smylie; Patricia J Martens; Nancy G L McHugh; Elena Labranche; Fabienne Simonet; Spogmai Wassimi; Katherine Minich; William D Fraser
Journal:  J Epidemiol Community Health       Date:  2010-11-04       Impact factor: 3.710

5.  Prevalence of gestational diabetes mellitus among James Bay Cree women in northern Quebec.

Authors:  S Rodrigues; E Robinson; K Gray-Donald
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 6.  Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress.

Authors:  T K Young; J Reading; B Elias; J D O'Neil
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  Association of macrosomia with perinatal and postneonatal mortality among First Nations people in Quebec.

Authors:  Spogmai Wassimi; Russell Wilkins; Nancy G L Mchugh; Lin Xiao; Fabienne Simonet; Zhong-Cheng Luo
Journal:  CMAJ       Date:  2011-01-17       Impact factor: 8.262

8.  A prospective cohort study of pregnancy risk factors and birth outcomes in Aboriginal women.

Authors:  Wanda M Wenman; Michel R Joffres; Ivanna V Tataryn
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

Review 9.  Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States.

Authors:  Catherine Chamberlain; Bridgette McNamara; Emily D Williams; Daniel Yore; Brian Oldenburg; Jeremy Oats; Sandra Eades
Journal:  Diabetes Metab Res Rev       Date:  2013-05       Impact factor: 4.876

10.  Effect of number of abnormal oral glucose tolerance test (OGTT) values on birthweight in women with gestational diabetes.

Authors:  Nermin Kösüs; Aydin Kösüs; Müzeyyen Duran; Nilgün O Turhan
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.